Evidence map›Paper›PMID 34462741›Full record

ArticlebioRxiv : the preprint server for biology2021

Deep immune profiling of the maternal-fetal interface with mild SARS-CoV-2 infection.

Suhas Sureshchandra, Michael Z Zulu, Brianna Doratt, Allen Jankeel, Delia Tifrea, Robert Edwards, Monica Rincon, Nicole E Marshall, Ilhem Messaoudi

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Suhas SureshchandraDepartment of Molecular Biology and Biochemistry, School of Biological Sciences, University of California, Irvine CA 92697.
Michael Z ZuluDepartment of Molecular Biology and Biochemistry, School of Biological Sciences, University of California, Irvine CA 92697.
Brianna DorattDepartment of Molecular Biology and Biochemistry, School of Biological Sciences, University of California, Irvine CA 92697.
Allen JankeelDepartment of Molecular Biology and Biochemistry, School of Biological Sciences, University of California, Irvine CA 92697.
Delia TifreaDepartment of Pathology and Laboratory Medicine, School of Medicine, University of California, Irvine CA 92697.
Robert EdwardsDepartment of Pathology and Laboratory Medicine, School of Medicine, University of California, Irvine CA 92697.
Monica RinconMaternal-Fetal Medicine, Oregon Health and Sciences University, Portland OR 97239.
Nicole E MarshallMaternal-Fetal Medicine, Oregon Health and Sciences University, Portland OR 97239.
Ilhem MessaoudiDepartment of Molecular Biology and Biochemistry, School of Biological Sciences, University of California, Irvine CA 92697.
University of California, Irvine · USOregon Health & Science University · US

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Melanie Funes · 1994 to 2026
$57.9M
University of California Health Participation in the National COVID Cohort Collaborative (N3C)UL1TR001414 · NCATS · UNIVERSITY OF CALIFORNIA-IRVINE · PI COOPER, DAN M, VILAIN, ERIC J. · 2015 to 2023
$35.1M
Dysregulation of maternal immunity during pregnancy by pregravid obesityR01AI145910 · NIAID · UNIVERSITY OF KENTUCKY · PI MESSAOUDI, ILHEM · 2019 to 2024
$3.4M
Maternal obesity and neonatal innate immunityR01AI142841 · NIAID · UNIVERSITY OF KENTUCKY · PI MESSAOUDI, ILHEM, VARLAMOV, OLEG · 2018 to 2024
$2.7M
NCATS NIH HHS UL1 TR001414NCI NIH HHS P30 CA062203NIAID NIH HHS R01 AI142841NIAID NIH HHS R01 AI145910
6 · The paper itself

Abstract

Pregnant women are an at-risk group for severe COVID-19, though the majority experience mild/asymptomatic disease. Although severe COVID-19 has been shown to be associated with immune activation at the maternal-fetal interface even in the absence of active viral replication, the immune response to asymptomatic/mild COVID-19 remains unknown. Here, we assessed immunological adaptations in both blood and term decidua from 9 SARS-exposed pregnant women with asymptomatic/mild disease and 15 pregnant SARS-naive women. In addition to selective loss of tissue-resident decidual macrophages, we report attenuation of antigen presentation and type I IFN signaling but upregulation of inflammatory cytokines and chemokines in blood monocyte derived decidual macrophages. On the other hand, infection was associated with remodeling of the T cell compartment with increased frequencies of activated CD69+ tissue-resident T cells and decreased abundance of Tregs. Interestingly, frequencies of cytotoxic CD4 and CD8 T cells increased only in the blood, while CD8 effector memory T cells were expanded in the decidua. In contrast to decidual macrophages, signatures of type I IFN signaling were increased in decidual T cells. Finally, T cell receptor diversity was significantly reduced with infection in both compartments, albeit to a much greater extent in the blood. The resulting aberrant immune activation in the placenta, even with asymptomatic disease may alter the exquisitely sensitive developing fetal immune system, leading to long-term adverse outcomes for offspring.

Identifiers

PMID34462741
PMCPMC8404883
OpenAlexW3195842194

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.